|
Asmacure Ltee to Present at the 2011 BioPharm America Conference
MarketWatch (press release) 1, 2011 /PRNewswire via COMTEX/ — Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, announced today that CEO Martin Driscoll … |
View full post on asthma – Google News